Glaukos Corporation (NYSE:GKOS) Q1 2025 Earnings Call Transcript
Operator: Welcome to Glaukos Corporation First Quarter 2025 Financial Results Conference Call.
Glaukos Corp (GKOS)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period: Filing is Ongoing
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | ZWEIG DIMENNA PARTNERS Joe Dimenna | 60,800 | $5,983,936 | +4% | 0.95% |
| 2. | Bayforest Capital Theodoros Tsagaris | 1,435 | $80,015 | 0.07% | |
| 3. | Altium Capital Jacob Gottlieb | 0 | $0 | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $23.84 | 2,100 | 102,100 | 2017-11-22 | Filing | ||
| $16.03 | 2,500 | 5,000 | 2016-03-04 | Filing | ||
| $15.30 | 1,388 | 1,388 | 2015-12-31 | Filing | ||
| $15.30 | 1,388 | 4,656 | 2015-12-31 | Filing | ||
| $21.83 | 2,500 | 2,500 | 2015-11-12 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $108.14 | 31 | 53,431 | 2025-03-25 | Filing | ||
| $107.44 | 430 | 53,462 | 2025-03-25 | Filing | ||
| $106.56 | 1,059 | 53,892 | 2025-03-25 | Filing | ||
| $120.72 | 20,687 | 54,249 | 2025-02-26 | Filing | ||
| $147.14 | 3,416 | 72,437 | 2025-02-14 | Filing |
Institutional Investors' Holdings
Filing Period: Filing is Ongoing
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 8,556,385 | $842,119,411 | 0.02% | |
| 2. | 5,965,115 | $587,086,618 | 0.01% | |
| 3. | 1,218,475 | $119,922,310 | 0.1% | |
| 4. | 1,084,184 | $106,705,389 | 0.52% | |
| 5. | 745,290 | $73,351,442 | 0.21% |
News See All
What Makes Glaukos Corporation (GKOS) a Compelling Stock?
ClearBridge Investments, an investment management company, released its “ClearBridge Small Cap Growth Strategy” first quarter 2025 investor letter. A copy of the letter can be downloaded here.
7 Best Medical Technology Stocks To Buy According To Analysts
The MedTech sector is crucial in healthcare, which concentrates on the creation of medical devices aimed at enhancing disease prevention, diagnosis, and treatment.
Glaukos Corporation (NYSE:GKOS) Q4 2024 Earnings Call Transcript
Operator: Welcome to Glaukos Corporation's Fourth Quarter and Full-Year 2024 Financial Results Conference Call.
Glaukos Corporation (NYSE:GKOS) Q3 2024 Earnings Call Transcript
Operator: Welcome to Glaukos Corporation's Third Quarter 2024 Financial Results Conference Call.
Here's Why Glaukos (GKOS) Appreciated in Q2
Brown Capital Management, an investment management company, released its “The Brown Capital Management Small Company Fund” second quarter 2024 investor letter.
Better Than Expected Earnings Results Boosted Glaukos Corp (GKOS) in Q2
Fred Alger Management, an investment management company, released its “Alger Weatherbie Specialized Growth Fund” second quarter 2024 investor letter. A copy of the letter can be downloaded here.
Should You Be Bullish on Glaukos Corporation (GKOS)?
Baron Funds, an investment management company, released its “Baron Health Care Fund” second quarter 2024 investor letter. A copy of the letter can be downloaded here.
Glaukos Corporation (NYSE:GKOS) Q2 2024 Earnings Call Transcript
Operator: Hello, and welcome to Glaukos Corporation's Second Quarter 2024 Financial Results Conference Call.
Glaukos Corporation (NYSE:GKOS) Q1 2024 Earnings Call Transcript
Operator: Welcome to Glaukos Corporation's First Quarter 2024 Financial Results Conference Call.